Clinical Trial Update: Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of anakinra for managing fever during neutropenia and mucositis in autologous stem cell transplant for multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED